Neuropediatrics 2005; 36(3): 186-192
DOI: 10.1055/s-2005-865611
Original Article

Georg Thieme Verlag KG Stuttgart · New York

Risk Factors for Fatality and Neurological Sequelae after Status Epilepticus in Children

Y. Maegaki1 , Y. Kurozawa2 , K. Hanaki3 , K. Ohno1
  • 1Division of Child Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago, Japan
  • 2Division of Health Administration and Promotion, Faculty of Medicine, Tottori University, Yonago, Japan
  • 3Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Yonago, Japan
Further Information

Publication History

Received: October 27, 2004

Accepted after Revision: March 25, 2005

Publication Date:
09 June 2005 (online)

Abstract

Using multivariate regression analysis, we examined risk factors for fatality and neurological sequelae after status epilepticus (SE) in children. Possible risk factors included sex, age at onset, the cause of SE, pyrexia, asthmatic attack during SE, past history of seizure, predisposing neurological abnormality, seizure duration, type of seizure, and medication with theophylline. Consecutive patients with SE, aged 1 month to 18 years, who were referred to Tottori University Hospital from 1984 to 2002 were reviewed. Of the 234 patients enrolled, 45 patients (19.2 %) showed poor outcomes, namely early death in 9 and neurological sequela in 36. Acute neurological insult and progressive neurological disease as the cause of SE were very significantly related to poor outcome (OR = 33.68, p = 0.000). We excluded 21 patients with the etiology of acute neurological insult and progressive neurological disease and then reanalyzed risk factors in the remaining 213 patients. Twenty-nine patients (13.6 %) showed poor outcome, namely early death in 6 and neurological sequela in 23. Seizure duration of more than 2 hours (OR = 12.73, p = 0.000) and moderate to severe asthmatic attack (OR = 31.61, p = 0.010) were associated with poor outcome. These results indicate that long-lasting seizure activity and asthmatic attack can exacerbate SE-associated brain injury.

References

  • 1 Aiba H, Mochizuki M, kimura M, Hojo H. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy.  Neurology. 2001;  57 295-299
  • 2 Bahls F H, Ma K K, Bird T D. Theophylline-associated seizures with “therapeutic” or low toxic serum concentrations: risk factors for serious outcome in adults.  Neurology. 1991;  41 1309-1312
  • 3 Barnard C, Wirrell E. Does status epilepticus in children cause developmental deterioration and exacerbation of epilepsy?.  J Child Neurol. 1999;  14 787-794
  • 4 Cilio M R, Sogawa Y, Cha B-H, Liu X, Huang L-T, Holmes G L. Long-term effects of status epilepticus in the immature brain are specific for age and model.  Epilepsia. 2003;  44 518-528
  • 5 Claassen J, Lokin J K, Fitzsimmons B FM, Mendelsohn F A, Mayer S A. Predictors of functional disability and mortality after status epilepticus.  Neurology. 2002;  58 139-142
  • 6 DeLorenzo R J, Hauser W A, Towne A R, Boggs J G, Pellock J M, Penberthy L. et al . A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia.  Neurology. 1996;  46 1029-1035
  • 7 Dunn D W. Status epilepticus in children: etiology, clinical features, and outcome.  J Child Neurol. 1988;  3 167-173
  • 8 Dunn D W, Parekh H U. Theophylline and status epilepticus in children.  Neuropediatrics. 1991;  22 24-26
  • 9 Ellenberg J H, Nelson K B. Febrile seizures and later intellectual performance.  Arch Neurol. 1978;  35 17-21
  • 10 Eriksson K J, Koivikko M J. Status epilepticus in children: aetiology, treatment, and outcome.  Dev Med Child Neurol. 1997;  39 652-658
  • 11 Fountain N B. Status epilepticus: risk factors and complications.  Epilepsia. 2000;  41 (Suppl 2) S23-30
  • 12 Fujikawa D G, Itabashi H H, Wu A, Shinmei S S. Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy.  Epilepsia. 2000;  41 981-991
  • 13 Ichiyama T, Nishikawa M, Yoshitomi T, Hayashi T, Furukawa S. Tumor necrosis factor-α, interleukin-1β, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures: comparison with acute encephalitis/encephalopathy.  Neurology. 1998;  50 407-411
  • 14 Knopman D, Margolis G, Reeves G. Prolonged focal epilepsy and hypoxemia as a cause of focal brain damage: a case study.  Ann Neurol. 1977;  1 195-198
  • 15 Liu Z, Gatt A, Kikati M, Holmes G L. Effect of temperature on kainic acid-induced seizures.  Brain Res. 1993;  631 51-58
  • 16 Lundgren J, Smith M-L, Blennow G, Siesjö. Hyperthermia aggravates and hypothermia ameliorates epileptic brain damage.  Exp Brain Res. 1994;  99 43-55
  • 17 Maegaki Y, Koeda T, Kawahara H, Takeshita K. Two cases of theophylline-associated encephalopathy in childhood: clinical and CT findings (in Japanese).  No To Hattatsu (Tokyo). 1993;  25 277-282
  • 18 Mathern G W, Price G, Rosales C, Pretorius J K, Lozada A, Mendoza D. Anoxia during kainate status epilepticus shortens behavioral convulsions but generates hippocampal neuron loss and supragranular mossy fiber sprouting.  Epilepsy Res. 1998;  30 133-151
  • 19 Maytal J, Shinnar S, Moshé S L, Alvarez L A. Low morbidity and mortality of status epilepticus in children.  Pediatrics. 1989;  83 323-331
  • 20 Meierkord H, Wieshmann U, Niehaus L, Lehmann R. Structural consequences of status epilepticus demonstrated with serial magnetic resonance imaging.  Acta Nurol Scand. 1997;  96 127-132
  • 21 Meldrum B S, Vigouroux R A, Brierley J B. Systemic factors and epileptic brain damage.  Arch Neurol. 1973;  29 82-87
  • 22 Morimoto T, Nagao H, Yoshimatsu M, Yoshida K, Matsuda H. Pathogenic role of glutamate in hyperthermia-induced seizures.  Epilepsia. 1993;  34 447-452
  • 23 National Asthma Education and Prevention Program .Expert panel report 2. Guidelines for the Diagnosis and Management of Asthma. No. 97 - 4051. Bethesda; NIH publication 1997: 105-121
  • 24 Nevander G, Ingvar M, Auer R, Siesjö B K. Status epilepticus in well-oxygenated rats causes neuronal necrosis.  Ann Neurol. 1985;  18 281-290
  • 25 Pascual-Castroviejo I, Pascual-Pascual S I, Peňa W, Talavera M. Status epilepticus-induced brain damage and opercular syndrome in childhood.  Dev Med Child Neurol. 1999;  41 420-423
  • 26 Shinnar S, Pellock J M, Berg A T, O'Dell C, Driscoll S M, Maytal J. et al . Short-term outcomes of children with febrile status epilepticus.  Epilepsia. 2001;  42 47-53
  • 27 Soffer D, Melamed E, Assaf Y, Cotev S. Hemispheric brain damage in unilateral status epilepticus.  Ann Neurol. 1986;  20 737-740
  • 28 Söderfeldt B, Blennow G, Kalimo H, Olsson Y, Siesjö K. Influence of systemic factors on experimental epileptic brain injury.  Acta Neuropathol. 1983;  60 81-91
  • 29 van Esch A, Ramlal I R, van Steensel-Moll H A, Steyerberg E W, Derksen-Lubsen G. Outcome after febrile status epilepticus.  Dev Med Child Neurol. 1996;  38 19-24
  • 30 Verity C M, Ross E M, Golding J. Outcome of childhood status epilepticus and lengthy febrile convulsions: findings of national cohort study.  BMJ. 1993;  307 225-228
  • 31 Walton N Y. Systemic effects of generalized convulsive status epilepticus.  Epilepsia. 1993;  34 (Suppl 1) S54-58
  • 32 Wasterlain C G, Niquet J, Thompson K W, Baldwin R, Liu H, Sankar R. et al . Seizure-induced neuronal death in the immature brain.  Prog Brain Res. 2002;  135 335-353
  • 33 Yokoyama H, Onodera K, Yagi T, Iinuma K. Therapeutic doses of theophylline exert proconvulsant effects in developing mice.  Brain Dev. 1997;  19 403-407
  • 34 Yoshikawa H, Yamazaki S, Watanabe T, Abe T. Study of influenza-associated encephalitis/encephalopathy in children during the 1997 to 2001 influenza seasons.  J Child Neurol. 2001;  16 885-890
  • 35 Young R K, During M J, Aquila W J, Tendler D, Ley E. Hypoxia increases extracellular concentrations of excitatory and inhibitory neurotransmitters in subsequently induced seizure: in vivo microdialysis study in the rabbit.  Exp Neurol. 1992;  117 204-209

M.D. Yoshihiro Maegaki

Division of Child Neurology
Institute of Neurological Sciences
Faculty of Medicine
Tottori University

36-1 Nishi-machi

Yonago 683-8504

Japan

Email: maegaki@grape.med.tottori-u.ac.jp